Study of INV-202 in Patients With Obesity and Metabolic Syndrome
Conditions: Obesity; Metabolic Syndrome Intervention: Drug: INV-202 Sponsor: Inversago Pharma Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2023 Category: Research Source Type: clinical trials
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
Conditions: Obesity; Metabolic Syndrome Interventions: Drug: INV-202; Drug: Placebo Sponsor: Inversago Pharma Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2023 Category: Research Source Type: clinical trials
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
Conditions: Obesity; Metabolic Syndrome Intervention: Drug: INV-202 Sponsor: Inversago Pharma Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2023 Category: Research Source Type: clinical trials